What are the clinical manifestations and pathophysiology of Post-Streptococcal Glomerulonephritis (PSGN)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 17, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Post-Streptococcal Glomerulonephritis: Pathophysiology and Clinical Manifestations

Pathophysiology

PSGN is an immune complex-mediated disease where streptococcal antigens trigger immune complex deposition in glomerular tissue, activating the complement system and causing glomerular inflammation and subsequent kidney damage. 1, 2

Immunologic Mechanism

  • The disease involves deposition of immune complexes in the glomeruli following infection with nephritogenic strains of group A β-hemolytic Streptococcus (Streptococcus pyogenes) 3, 4
  • Two key streptococcal antigens are implicated: nephritis-associated plasmin receptor (identified as glyceraldehyde-3-phosphate dehydrogenase) and the cationic cysteine proteinase streptococcal pyrogenic exotoxin B 4
  • The complement system is activated primarily via the alternative pathway, though the lectin pathway also contributes, generating inflammation at sites of immune complex deposition 5, 4
  • This immune-mediated process results in acute diffuse proliferative glomerulonephritis 4

Temporal Relationship

  • PSGN typically occurs 1-3 weeks after streptococcal pharyngitis 1, 6
  • Following impetigo (skin infection), the latency period extends to 4-6 weeks 1

Histopathologic Features

  • Glomeruli are diffusely affected with enlarged glomerular tufts due to hypercellularity 4
  • Endocapillary hypercellularity is present, characterized by increased numbers of cells within glomerular capillary lumina causing luminal narrowing 7
  • Mesangial proliferation with proliferative endothelial and mesangial cells is observed 4
  • Subepithelial "humps" (electron-dense deposits) are typically seen on electron microscopy in infection-related glomerulonephritis 7
  • Exudative patterns may occur with neutrophils accounting for >50% of glomerular hypercellularity 7
  • In severe cases, crescentic glomerulonephritis with cellular, fibrocellular, or fibrous crescents may develop 7

Clinical Manifestations

The classic presentation is acute nephritic syndrome occurring 1-3 weeks post-pharyngitis or 4-6 weeks post-impetigo, characterized by hematuria with red blood cell casts, hypertension, edema, and oliguria. 1, 5

Cardinal Features of Nephritic Syndrome

  • Hematuria: Microscopic or gross (red to brown "tea-colored" or "cola-colored" urine) with glomerular red blood cell casts on urinalysis 1, 3, 5
  • Hypertension: Present in approximately 95% of patients in the acute phase, typically mild and short-term 8
  • Edema: Periorbital and peripheral edema due to sodium and water retention 3, 5
  • Oliguria: Reduced urine output secondary to decreased glomerular filtration 3, 5

Laboratory Abnormalities

  • Proteinuria: Ranges from mild to nephrotic range (>3.5 g/day or protein-creatinine ratio >3.5) 1, 3
  • Acute kidney injury: Elevated serum creatinine and decreased estimated glomerular filtration rate (eGFR), which can be severe (GFR as low as 11.2 ml/min/1.73 m² in severe cases) 3
  • Low C3 complement: Hallmark finding that should normalize within 8-12 weeks; persistently low C3 beyond 12 weeks warrants kidney biopsy to exclude C3 glomerulonephritis 1, 6
  • Normal C4 complement: Helps differentiate PSGN from other forms of glomerulonephritis 1
  • Elevated streptococcal antibodies: Anti-streptolysin O (ASO), anti-DNAse B, and anti-hyaluronidase titers 1, 3
  • Hyperuricemia: May be present in severe cases 3

Severe Complications

  • Hypertensive emergencies: Require urgent blood pressure control 5
  • Congestive heart failure: Due to volume overload and hypertension 5
  • Severe acute kidney injury: May necessitate dialysis 1, 5
  • Rapidly progressive glomerulonephritis: Crescentic disease with rapid decline in renal function 5
  • Nephrotic syndrome: Occasionally presents with heavy proteinuria, hypoalbuminemia, and edema 5

Clinical Presentation Variability

  • Presentation ranges from asymptomatic microscopic hematuria discovered incidentally to full nephritic syndrome with complications 9, 4
  • Fatigue, shortness of breath, and signs of fluid overload may be present 7
  • In the context of ongoing infection, patients may show signs of sepsis with very high inflammatory markers 3

Long-Term Manifestations

  • Hypertension persisting beyond the acute phase (present in approximately 6.8% of patients at 2-5 years follow-up) is a poor prognostic sign associated with development of glomerulosclerosis and potential progression to chronic kidney disease 8
  • Persistent proteinuria and hematuria may require long-term monitoring 5

References

Guideline

Management of Post-Streptococcal Glomerulonephritis (PSGN)

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Primary Pathophysiology of Post-Streptococcal Glomerulonephritis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Acute post-streptococcal glomerulonephritis in children - treatment standard.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2025

Guideline

Treatment of Post-Infectious Glomerulonephritis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Related Questions

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.